famotidine and atropine

famotidine has been researched along with atropine in 23 studies

Research

Studies (23)

TimeframeStudies, this research(%)All Research%
pre-19901 (4.35)18.7374
1990's6 (26.09)18.2507
2000's8 (34.78)29.6817
2010's8 (34.78)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kodama, H; Kuratani, K; Yamaguchi, I; Yamazaki, M1
Maeno, H; Takagi, T; Takeda, M1
Maeda, N; Nomura, K; Yamaguchi, I; Yoshino, T1
Classen, M; Schepp, W; Schusdziarra, V; Wünsch, E; Zimmerhackl, B1
Copius Peereboom-Stegeman, JH; Russel, FG; Van der Aa, EM; Wouterse, AC1
Akuzawa, S; Miyata, K; Nishida, A; Takemoto, Y; Uchida-Kobayashi, A1
Akuzawa, S; Ito, H; Miyake, A; Miyata, K; Nishida, A; Takemoto, Y; Takinami, Y; Yuki, H1
Hosoda, H; Inomata, N; Itoh, Z; Kangawa, K; Kojima, M; Masuda, Y; Ohnuma, N; Tanaka, S; Tanaka, T1
Ben, M; Kupie, TC; Trissel, LA; Trusley, C1
Mojtahedin, A; Tamaddonfard, E; Zanbouri, A1
Czimmer, J; Mózsik, G; Szabó, IL; Szolcsányi, J1
Topliss, JG; Yoshida, F1
Lombardo, F; Obach, RS; Waters, NJ1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Glen, RC; Lowe, R; Mitchell, JB1
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ1
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1

Reviews

2 review(s) available for famotidine and atropine

ArticleYear
Molecular pharmacological approaches to effects of capsaicinoids and of classical antisecretory drugs on gastric basal acid secretion and on indomethacin-induced gastric mucosal damage in human healthy subjects (mini review).
    Current pharmaceutical design, 2013, Volume: 19, Issue:1

    Topics: Adult; Afferent Pathways; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Atropine; Capsaicin; Cimetidine; Dose-Response Relationship, Drug; Famotidine; Female; Gastric Acid; Gastric Mucosa; Humans; Indomethacin; Male; Omeprazole; Peptic Ulcer; Ranitidine

2013
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

2 trial(s) available for famotidine and atropine

ArticleYear
In man histamine and muscarinergic mechanisms are essential mediators of acid secretion in response to synthetic human gastrin (1-17).
    Regulatory peptides, 1993, Jul-23, Volume: 46, Issue:3

    Topics: Adult; Atropine; Eating; Famotidine; Female; Gastric Acid; Gastrins; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Infusions, Intravenous; Injections, Intravenous; Male; Muscarinic Antagonists; Random Allocation

1993
Molecular pharmacological approaches to effects of capsaicinoids and of classical antisecretory drugs on gastric basal acid secretion and on indomethacin-induced gastric mucosal damage in human healthy subjects (mini review).
    Current pharmaceutical design, 2013, Volume: 19, Issue:1

    Topics: Adult; Afferent Pathways; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Atropine; Capsaicin; Cimetidine; Dose-Response Relationship, Drug; Famotidine; Female; Gastric Acid; Gastric Mucosa; Humans; Indomethacin; Male; Omeprazole; Peptic Ulcer; Ranitidine

2013

Other Studies

20 other study(ies) available for famotidine and atropine

ArticleYear
Possible involvement of hyperinsulinemia and adrenergic activation in the pathogenesis of indomethacin-induced antral ulcers in nonfasted hamsters and refed rats.
    The Journal of pharmacology and experimental therapeutics, 1992, Volume: 263, Issue:3

    Topics: Animals; Atropine; Cricetinae; Famotidine; Fasting; Indomethacin; Insulin; Male; Mesocricetus; Prazosin; Propranolol; Pyloric Antrum; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic; Stomach Ulcer; Streptozocin; Yohimbine

1992
Kinetics of antisecretory action of a new H2-antagonist, YM-11170, in conscious dogs.
    European journal of pharmacology, 1983, Aug-05, Volume: 91, Issue:4

    Topics: Animals; Atropine; Cimetidine; Dimaprit; Dogs; Famotidine; Gastric Acid; Gastric Mucosa; Histamine H2 Antagonists; Kinetics; Male; Methacholine Chloride; Methacholine Compounds; Pentagastrin; Thiazoles; Thiourea

1983
Different mechanisms mediated by dopamine D1 and D2 receptors are involved etiologically in activity-stress gastric lesion of the rat.
    The Journal of pharmacology and experimental therapeutics, 1995, Volume: 273, Issue:3

    Topics: Animals; Atropine; Cerebral Cortex; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Famotidine; Male; Motor Activity; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Stomach Ulcer; Stress, Physiological

1995
Inhibition of choline uptake in syncytial microvillus membrane vesicles of human term placenta. Specificity and nature of interaction.
    Biochemical pharmacology, 1995, Nov-27, Volume: 50, Issue:11

    Topics: Atropine; Carrier Proteins; Choline; Cholinergic Antagonists; Cimetidine; Dose-Response Relationship, Drug; Famotidine; Female; Hemicholinium 3; Histamine H2 Antagonists; Humans; In Vitro Techniques; Maternal-Fetal Exchange; Membrane Transport Proteins; Microvilli; Neurotransmitter Uptake Inhibitors; Placenta; Pregnancy; Ranitidine; Tetraethylammonium Compounds; Trophoblasts

1995
Comparative evaluation of the role of endogenous gastrin in basal acid secretion in conscious rats provided with chronic fistula and pylorus ligation.
    Japanese journal of pharmacology, 1996, Volume: 71, Issue:3

    Topics: Animals; Atropine; Benzodiazepines; Chronic Disease; Famotidine; Gastric Acid; Gastric Fistula; Gastrins; Histamine; Ligation; Male; Parasympathetic Nervous System; Pylorus; Rats; Rats, Sprague-Dawley

1996
YM022, a potent and selective gastrin/CCK-B receptor antagonist, inhibits peptone meal-induced gastric acid secretion in Heidenhain pouch dogs.
    Digestive diseases and sciences, 1997, Volume: 42, Issue:4

    Topics: Animals; Atropine; Benzodiazepines; Benzodiazepinones; Devazepide; Dogs; Dose-Response Relationship, Drug; Eating; Famotidine; Gastric Acid; Histamine; Histamine H2 Antagonists; Hormone Antagonists; Male; Methacholine Chloride; Muscarinic Antagonists; Pentagastrin; Peptones; Phenylurea Compounds; Receptors, Cholecystokinin; Sincalide; Stomach

1997
Ghrelin stimulates gastric acid secretion and motility in rats.
    Biochemical and biophysical research communications, 2000, Oct-05, Volume: 276, Issue:3

    Topics: Animals; Atropine; Dose-Response Relationship, Drug; Famotidine; Gastric Acid; Gastric Mucosa; Ghrelin; Histamine; Histamine H2 Antagonists; Male; Peptide Hormones; Peptides; Peristalsis; Rats; Rats, Sprague-Dawley; Stomach; Vagotomy

2000
Physical and chemical stability of palonosetron hydrochloride with five common parenteral drugs during simulated Y-site administration.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2008, Sep-15, Volume: 65, Issue:18

    Topics: Antiemetics; Atropine; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Incompatibility; Drug Stability; Famotidine; Heparin; Infusions, Intravenous; Isoquinolines; Lidocaine; Nephelometry and Turbidimetry; Palonosetron; Pharmaceutical Solutions; Potassium Chloride; Quinuclidines; Serotonin Antagonists

2008
Effects of mepyramine and famotidine on the physostigmine-induced antinociception in the formalin test in rats.
    Pakistan journal of biological sciences : PJBS, 2008, Nov-15, Volume: 11, Issue:22

    Topics: Analgesics; Animals; Atropine; Drug Interactions; Famotidine; Formaldehyde; Histamine H1 Antagonists; Histamine H2 Antagonists; Male; Muscarinic Antagonists; Pain; Pain Measurement; Physostigmine; Pyrilamine; Rats; Rats, Wistar; Receptors, Muscarinic

2008
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
    Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19

    Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
    European journal of medicinal chemistry, 2009, Volume: 44, Issue:11

    Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Predicting phospholipidosis using machine learning.
    Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5

    Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine

2010
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics

2010
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:1

    Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics

2011
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013